Case ReportPublished 6 October 2026Case Report: Light chain amyloidosis in a patient with low-grade B-cell lymphomaAlex Matthaeus · David Thomas · Hakan R. TokaFrontiers in Nephrologydoi 10.3389/fneph.2026.1959759
Original ResearchPublished 24 September 2026Integrative multi-omics characterization of KLRB1/CD161 in diffuse large B-cell lymphoma: associations with immune context, subtype biology, and therapeutic responseErwei Li · Yingying Tang · Yuanyuan Wanyan · Yu LiangFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1903725
ReviewPublished 13 August 2026Functional genomics–guided design of CAR-T and CAR-NK therapies in hematological malignancies: aligning cellular engineering with immune escape and microenvironmental resistanceShiqi Cai · Yang Tan · Qian Yang · Juan HuangFrontiers in Genome Editingdoi 10.3389/fgeed.2026.1878460
ReviewPublished 7 July 2026Post-transplant lymphoproliferative disorder after solid organ transplantation: a comprehensive reviewLina Patricia Vargas-Nieto · Nicolás David Santoyo-Sarmiento · Maria Ballesteros-García · Angie Tatiana Calderón-Vásquez · Álvaro Daniel Pinto-Rodriguez · Maria Gabriela Robayo-Romero · Valeria Cormane-Alfaro · Jorge Daza-BuitragoFrontiers in Transplantationdoi 10.3389/frtra.2026.1869288
Original ResearchPublished 17 June 2026Clinical presentation, management, and outcomes of post-transplant lymphoproliferative disorder in renal and pancreas transplantation: a 22-year experienceKian Emami · Jane Norman · Titus AugustineFrontiers in Transplantationdoi 10.3389/frtra.2026.1830197
Hypothesis and TheoryPublished 10 June 2026The cells of origin of the chemotherapy-curable malignancies are highly sensitive to cytotoxic chemotherapy-mediated cell deathEmily Proudman · Philip SavageFrontiers in Hematologydoi 10.3389/frhem.2026.1814036
ReviewPublished 11 May 2026Bridging innovation and equity: the evolving landscape of CAR T-cell therapy access in BrazilRenato Luiz Guerino-Cunha · Andreia Bessa · Angela Marie Jansen · Martha Oliveira · Gayatri Sanku · Rogerio Scarabel · Jayr Schmidt-Filho · Stephen StefaniFrontiers in Hematologydoi 10.3389/frhem.2026.1813861
Case ReportPublished 30 March 2026Case Report: Burkitt’s lymphoma with concurrent HIV, CMV encephalitis, and salmonella bacteremiaElinor Barsh · Michele Basche · Dmitriy ScherbakFrontiers in Hematologydoi 10.3389/frhem.2026.1727954
Case ReportPublished 23 January 2026Case Report: Durable response to PD-1 blockade after failure of ALK-targeted therapy and chemoimmunotherapy in ALK-positive large B-cell lymphomaGuilherme Gasparini Spiandorelo · Ahmed Alnughmush · Olivia Crum · Dragan Jevremovic · J. C. VillasboasFrontiers in Hematologydoi 10.3389/frhem.2025.1683981
ReviewPublished 11 November 2025A focus on LBCL patients in partial remission in the CAR-T eraGiuseppe Tarantini · Elena Arcuti · Caterina Buquicchio · Vera Carluccio · Gaetano De Santis · Candida Rosaria Germano · Mariangela Leo · Daria Carmela Loconte · Sonia Mallano · Rosanna Maria Miccolis · Teresa Maria Santeramo · Vanda Strafella · Vincenzo PavoneFrontiers in Hematologydoi 10.3389/frhem.2025.1675099
Science archivePublished 8 October 2025Case Report: Blister formation with transient drug hypersensitivity following CAR-T-cell therapyNatsu Watanabe · Nobuo Kanazawa · Satoshi YoshiharaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.15280
Science archivePublished 8 April 2025Diffuse large B-cell lymphoma misdiagnosed as cellulitisTamotsu Kuribayashi · Mayumi Komine · Mayumi Baba · Nobuhito Ohnou · Yoshinori MoritaJournal of Cutaneous Immunology and Allergydoi 10.3389/jcia.2025.14541
